Locametz Injection, Powder, Lyophilized, For Solution
Product Images NDC 0078-1224

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Locametz (NDC 0078-1224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Reconstitution Procedure For Eckert & Ziegler Galliapharm Generator (Locametz 01)

A flow diagram illustrating the preparation process for gallium Ga 68 gozetotide. It starts with a GalliaPharm Generator producing a Ga 68 eluate, which combines with lyophilisate, followed by a vent during elution. The mixture is incubated at 20°C to 30°C for 5 minutes to form gallium Ga 68 gozetotide. A test sample is taken, and appearance, pH, and radiochemical purity are assessed. Depending on results, the product is either discarded or passes final conformity checks.*

FDA Label Image

Figure 2. Reconstitution Procedure For Ire Elit Galli Eo Generator (Locametz 02)

A flowchart illustrating the preparation process of gallium Ga 68 gozetotide from a 68Ge/68Ga GalliAd/GalliEo Generator eluate. It shows elution, incubation of lyophilisate, sample testing, and quality checks including appearance, pH, and radiochemical purity, with decision points for conformity or discarding the product.*

FDA Label Image

Figure 3. Chemical Structure Of Gallium Ga 68 Gozetotide (Locametz 03)

Chemical structure of gallium Ga 68 gozetotide, the active ingredient in LOCAMETZ injection, powder, lyophilized for solution. The diagram shows the molecular structure including gallium complexed within the compound.*

FDA Label Image

Principal Display Panel Locametz® Kit For The Preparation Of Gallium Ga 68 Gozetotide Injection 25 Mcg Per Vial Gozetotide For Intravenous Use Only Radiolabel With Gallium-68 Chloride Before Use Rx Only Ndc 0078-1224-61 Novartis Pharmaceuticals Corporation East Hanover, Nj 07936 (Locametz 04)

LOCAMETZ kit for the preparation of gallium Ga 68 gozetotide injection 25 mcg per vial powdered lyophilized formulation for intravenous use. The packaging highlights storage and radiolabeling instructions, including temperature requirements and radiation precautions. Labeler information shows Novartis Pharmaceuticals Corporation, East Hanover, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.